BioStore™ Automated Cryogenic Storage System
Azenta's new BioStore Cryogenic Automated Sample Storage System with a Smaller Footprint
Next-generation automated cryogenic storage solutions, optimized to better suit the limited space available in today’s busy laboratories. Manage high-value inventories which require documented, repeatable processes with greater space efficiency.
Designed to fit spaces under the standard 8 feet ceiling height, this new BioStore storage system gives you the sample security and inventory management you need within a smaller footprint. Key features of Azenta’s new BioStore automated sample storage system are:
Space Efficiency: Industrial design that better fits customer facing application - for more samples stored in a limited space
Process control and risk mitigation: Precise cold chain handling and documentation; repeatable processes, secure login access and onboard monitoring with alarms
Data collection and audit support: Real-time inventory control and reporting; traceability and monitoring for sample safety and future regulatory compliance
Product classification BioStore™ Automated Cryogenic Storage System
Request information about BioStore™ Automated Cryogenic Storage System now
BioStore™ Automated Cryogenic Storage System
Azenta's new BioStore Cryogenic Automated Sample Storage System with a Smaller Footprint
Find more %topic% and related products
Find BioStore™ Automated Cryogenic Storage System and related products in the theme worlds
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
